RECURRENT PRIMARY MEDIASTINAL (THYMIC) LARGE B-CELL CELL LYMPHOMA
Clinical trials for RECURRENT PRIMARY MEDIASTINAL (THYMIC) LARGE B-CELL CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT PRIMARY MEDIASTINAL (THYMIC) LARGE B-CELL CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for RECURRENT PRIMARY MEDIASTINAL (THYMIC) LARGE B-CELL CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New 'Double-Target' cell therapy tested for tough blood cancers
Disease control OngoingThis early-phase study is testing the safety and best dose of a new type of CAR-T cell therapy for patients with B-cell lymphomas or chronic lymphocytic leukemia that have come back or not responded to standard treatments. Doctors modify a patient's own immune T-cells to recogniz…
Matched conditions: RECURRENT PRIMARY MEDIASTINAL (THYMIC) LARGE B-CELL CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Scientists test new drug duo in fight against tough lymphomas
Disease control OngoingThis early-stage study is testing a combination of two drugs, pembrolizumab and vorinostat, for people with certain types of lymphoma that have come back or not responded to prior treatments. The main goals are to check the safety of the combination and find the best dose of vori…
Matched conditions: RECURRENT PRIMARY MEDIASTINAL (THYMIC) LARGE B-CELL CELL LYMPHOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Targeted attack on stubborn lymphoma shows promise
Disease control OngoingThis study is testing a new combination of drugs for people with an aggressive type of lymphoma that has returned or not responded to the first treatment. The treatment combines a targeted antibody-drug with standard chemotherapy and immunotherapy. The goal is to see if this comb…
Matched conditions: RECURRENT PRIMARY MEDIASTINAL (THYMIC) LARGE B-CELL CELL LYMPHOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC